A rare confluence: chronic myeloid leukemia in a pediatric case of beta thalassemia

Read full text
Authors: Preeti Agrawal, Lavanya Raghavan, Arpit Mittal
Cited by: 0
References: 4

Abstract

Chronic myeloid leukemia (CML) is rare in children and extremely uncommon in patients with underlying hemoglobinopathies such as beta thalassemia. This report describes a 12‑year‑old beta thalassemia patient, who presented with fever, pallor and weakness, and was found to have marked hepatosplenomegaly and leukocytosis. Peripheral blood showed leukocytosis with increased myeloid precursors and bone marrow evaluation showed hypercellular marrow with myeloid hyperplasia and basophilia, consistent with a chronic myeloproliferative neoplasm. Karyotyping revealed balanced reciprocal translocation t (9;22) and reverse‑transcriptase polymerase chain reaction (RT‑PCR) detected BCR‑ABL1 p210 fusion transcript, confirming the diagnosis of chronic phase CML in a background of beta thalassemia. The patient had elevated serum ferritin, indirect hyperbilirubinemia and mildly deranged transaminases, attributable to chronic transfusions and iron overload. After initiation of appropriate therapy, leukocyte counts normalized within one month along with disappearance of circulating immature myeloid precursors. This case highlights the importance of maintaining a high index of suspicion for CML in thalassemic patients with unexplained leukocytosis and splenomegaly, and underscores the need for integrated morphologic, cytogenetic and molecular work-up to distinguish disease progression from a second primary hematologic malignancy.

Fields of Study & Subjects

Chronic Myeloid Leukemia Treatments Acute Myeloid Leukemia Research Myeloproliferative Neoplasms: Diagnosis and Treatment

Publication details

Journal / source
International Journal of Contemporary Pediatrics
Volume
13
Issue
2
Pages
328–330
Publication date
27 January 2026